These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37606168)
1. METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis. Chu S; Li Y; Wu B; Rong G; Hou Q; Zhou Q; Du D; Li Y Cell Transplant; 2023; 32():9636897231188300. PubMed ID: 37606168 [TBL] [Abstract][Full Text] [Related]
2. METTL3-mediated m Ji G; Wang X; Xi H Int J Immunopathol Pharmacol; 2023; 37():3946320231204694. PubMed ID: 37823387 [TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma. Chen J; Wu Z; Zhang Y Int J Immunopathol Pharmacol; 2019; 33():2058738418820743. PubMed ID: 30791797 [TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis. Sun ZP; Tan ZG; Peng C; Yi WM J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA SNHG3 promotes glioma tumorigenesis by sponging miR-485-5p to upregulate LMX1B expression. Guo X; Zheng J; Yu MJ; Piao HZ; Zhao HY Kaohsiung J Med Sci; 2021 Oct; 37(10):851-862. PubMed ID: 34153159 [TBL] [Abstract][Full Text] [Related]
6. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway. Kang R; Yao DF; Xu GZ; Zhou YH Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668 [TBL] [Abstract][Full Text] [Related]
7. METTL3-Mediated m Mao Y; Li W; Weng Y; Hua B; Gu X; Lu C; Xu B; Xu H; Wang Z Cell Transplant; 2022; 31():9636897221122997. PubMed ID: 36073002 [TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG3 is responsible for the deterioration of colorectal carcinoma through regulating the miR-370-5p/EZH1 axis. Zhang Y; Li L; Lu KX; Yu LB; Meng J; Liu CY Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):6131-6137. PubMed ID: 34661273 [TBL] [Abstract][Full Text] [Related]
9. HNRNPA2B1-mediated m Li K; Gong Q; Xiang XD; Guo G; Liu J; Zhao L; Li J; Chen N; Li H; Zhang LJ; Zhou CY; Wang ZY; Zhuang L J Transl Med; 2023 Jun; 21(1):382. PubMed ID: 37308993 [TBL] [Abstract][Full Text] [Related]
10. lncRNA SNHG3 accelerates the proliferation and invasion of non-small cell lung cancer by downregulating miR-340-5p. He WW; Ma HT; Guo X; Wu WM; Gao EJ; Zhao YH J Biol Regul Homeost Agents; 2020; 34(6):2017-2027. PubMed ID: 33225676 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway. Jiang H; Li X; Wang W; Dong H BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233 [TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326. Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493 [TBL] [Abstract][Full Text] [Related]
13. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A. Huang Y; Guan Y; Zhang X Mol Biotechnol; 2024 Aug; 66(8):1942-1953. PubMed ID: 37498409 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA SNHG3 interacts with microRNA-502-3p to mediate ITGA6 expression in liver hepatocellular carcinoma. Guo J; Zhang J; Xiang Y; Zhou S; Yang Y; Zheng J Cancer Sci; 2024 Jul; 115(7):2286-2300. PubMed ID: 38680094 [TBL] [Abstract][Full Text] [Related]
15. m Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312 [TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis. Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993 [TBL] [Abstract][Full Text] [Related]
17. Glycolysis related lncRNA SNHG3 / miR-139-5p / PKM2 axis promotes castration-resistant prostate cancer (CRPC) development and enzalutamide resistance. Yao Y; Chen X; Wang X; Li H; Zhu Y; Li X; Xiao Z; Zi T; Qin X; Zhao Y; Yang T; Wang L; Wu G; Fang X; Wu D Int J Biol Macromol; 2024 Mar; 260(Pt 2):129635. PubMed ID: 38266860 [TBL] [Abstract][Full Text] [Related]
18. Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer. Zhang M; Bai M; Wang L; Lu N; Wang J; Yan R; Cui M; Yan H; Zhang L Cancer Cell Int; 2021 Feb; 21(1):114. PubMed ID: 33596916 [TBL] [Abstract][Full Text] [Related]
19. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p. Long J; Pi X Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164 [TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG3 Promotes Proliferation and Metastasis of Non-Small-Cell Lung Cancer Cells Through miR-515-5p/SUMO2 Axis. Li Y; Gao L; Zhang C; Meng J Technol Cancer Res Treat; 2021; 20():15330338211019376. PubMed ID: 34032148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]